AU Patent

AU2019218232B2 — Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent

Assigned to Decibel Therapeutics Inc · Expires 2024-12-19 · 1y expired

What this patent protects

Hypertonic pharmaceutical compositions are disclosed. The hypertonic pharmaceutical compositions contain an anti-platinum chemoprotectant agent and a gelling agent. Also disclosed are methods of medical use of the hypertonic pharmaceutical compositions.

USPTO Abstract

Hypertonic pharmaceutical compositions are disclosed. The hypertonic pharmaceutical compositions contain an anti-platinum chemoprotectant agent and a gelling agent. Also disclosed are methods of medical use of the hypertonic pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019218232B2
Jurisdiction
AU
Classification
—
Expires
2024-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Decibel Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.